nufacturing Allogeneic Therapies at Scale to Deliver Reliable MultiPatient Supply

  •  Standardizing allogeneic manufacturing workflows to reduce variability and enable reproducible, multi-patient production
  • Optimizing cryopreservation strategies to maintain cell viability during long-term store and ensure reliable global distribution
  • Automating upstream and downstream workflows to increase output, reduce manual intervention, and control manufacturing costs